Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

488
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
488
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

638
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
638
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma signals of lung tumor promotion for molecular cancer prevention.

Cell·2026
Same author

Mechanisms, Microenvironments, and Models: Understanding Therapeutic Resistance in Glioblastoma.

International journal of radiation oncology, biology, physics·2026
Same author

Mapping intratumor heterogeneity across layers for advancing immunotherapy.

Cell·2026
Same author

Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.

Science (New York, N.Y.)·2026
Same author

The CD8 immgenT framework as a universal reference of mouse CD8αβ T cell differentiation states.

bioRxiv : the preprint server for biology·2026
Same author

Lymph node resident memory T cells retain effector capabilities by evading lung resident memory dysfunction.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Aug 22, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.2K

Once upon a prime: DCs shape cancer immunity.

Maria Zagorulya1, Stefani Spranger2

  • 1Department of Biology, MIT, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.

Trends in Cancer
|November 10, 2022
PubMed
Summary

Dendritic cells (DCs) are crucial for regulating the killing ability of cytotoxic CD8+ T cells, which is often impaired in cancer. Understanding DC signals can help reverse T cell dysfunction and improve antitumor immunity.

Keywords:
T cell primingantitumor immunitycancer immunotherapycytotoxic T cellsdendritic cellsstimulatory signals

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

11.9K
Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
13:36

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

3.6K

Related Experiment Videos

Last Updated: Aug 22, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.2K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

11.9K
Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
13:36

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

3.6K

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Immunology

Background:

  • Cytotoxic CD8+ T cells are vital for eliminating diseased cells, but their effectiveness is diminished in cancerous conditions.
  • Antitumor T cell immunity quality is shaped during initial T cell activation in lymph nodes and modulated by the tumor's microenvironment.
  • Dendritic cells (DCs) are increasingly recognized for their role in controlling the functional quality of T cell responses in both primary and secondary lymphoid organs.

Purpose of the Study:

  • To review recent advancements in understanding how specific signals from dendritic cells (DCs) influence the differentiation and antitumor functions of CD8+ T cells.
  • To explore the mechanisms by which DCs regulate CD8+ T cell responses in the context of cancer immunity.

Main Methods:

  • Literature review of recent research on dendritic cell function and CD8+ T cell responses in cancer.
  • Analysis of studies detailing DC-derived signals and their impact on T cell differentiation and effector functions.
  • Synthesis of current knowledge on DC-mediated regulation of antitumor immunity.

Main Results:

  • Distinct DC-derived signals play a critical role in directing CD8+ T cell differentiation pathways.
  • DC signals significantly influence the functional capacity and antitumor activities of CD8+ T cells.
  • The tumor microenvironment and lymph node priming, both influenced by DCs, are key determinants of T cell quality.

Conclusions:

  • Understanding the intricate mechanisms of DC-mediated regulation of CD8+ T cell responses is essential for cancer immunotherapy.
  • Targeting DC-derived signals offers potential strategies to enhance antitumor immunity and overcome T cell dysfunction in cancer patients.
  • Further research into DC-T cell interactions could lead to novel therapeutic approaches for cancer treatment.